Related Experiment Videos
[Myocardial revascularization and ischemic heart failure]
1Service de cardiologie B, CHU Nancy-Brabois, Vandoeuvre-lès-Nancy.
Insights
Myocardial revascularisation, including angioplasty and coronary bypass surgery, offers significant benefits for patients with ischaemic heart failure. These procedures can improve outcomes and are crucial in managing this condition.
Area of Science:
- Cardiology
- Vascular Surgery
Context:
- Ischaemic heart failure leads to increased hospital admissions and mortality.
- Severe cases and cardiogenic shock may benefit from coronary reperfusion and aortic balloon pump counter-pulsation.
- Coronary bypass surgery is emerging as a viable alternative to cardiac transplantation for specific patient groups.
Purpose:
- To review the benefits and outcomes of myocardial revascularisation in ischaemic heart failure.
- To differentiate the mechanisms of ischaemic left-ventricular dysfunction (hibernation vs. stunning).
- To compare the efficacy and long-term benefits of angioplasty versus coronary bypass surgery.
Summary:
- Myocardial revascularisation is a key treatment for ischaemic heart failure.
- Coronary bypass surgery and angioplasty show both immediate and long-term benefits.
- Hibernation, a cause of left-ventricular dysfunction, specifically requires revascularisation to prevent irreversible damage.
Impact:
- Myocardial revascularisation is an essential therapeutic option for ischaemic heart failure.
- Understanding physiopathological mechanisms guides treatment decisions.
- Revascularisation strategies improve patient outcomes and reduce mortality rates.
Abstract:
Ischaemic heart failure is the cause of an increased number of hospital admissions and death rate. In severe heart failure and cardiogenic shock, coronary reperfusion associated or not with aortic balloon pump counter-pulsation, seems to be beneficial. Moreover, it has recently shown that coronary bypass surgery may be a reasonable alternative to cardiac transplantation in coronary patients with severe heart failure. In the chronic phase, two physiopathological conditions have been proposed to explain the mechanism of ischaemic left-ventricular dysfunction: myocardial hibernation and stunning. Only hibernation requires revascularisation to avoid irreversible myocardial damage. The CASS group and others have demonstrated a real benefit from surgery although the operative risk is greater. Angioplasty has also been shown to be effective in terms of primary success with a relatively low complication rate. Compared one with another, angioplasty seems to provide better immediate results whereas surgery is associated with more long-term benefits. Myocardial revascularisation is therefore part of the therapeutic arsenal in cases of ischaemic heart failure.